Branched-chain amino acids alter neurobehavioral function in rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 304, Issue 4, 2013, Pages

  Coppola, Anna ^a,b   Wenner, Brett R ^a   Ilkayeva, Olga ^a   Stevens, Robert D ^a,b   Maggioni, Mauro ^a   Slotkin, Theodore A ^b   Levin, Edward D ^b   Newgard, Christopher B ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Branched chain amino acids; Mood disorders; Obesity; Tryptophan

Indexed keywords

BRANCHED CHAIN AMINO ACID; CARBOHYDRATE; FAT; FLUOXETINE; KYNURENIC ACID; PROTEIN; SEROTONIN; SEROTONIN RECEPTOR; SUCROSE; TRYPTOPHAN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CALORIC INTAKE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXPLORATORY BEHAVIOR; LIPID DIET; LIQUID CHROMATOGRAPHY; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTAKE; RAT; SEROTONIN BRAIN LEVEL; SYNAPSE; TANDEM MASS SPECTROMETRY;

AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN; DIET; DIET, HIGH-FAT; DIETARY SUCROSE; EXPLORATORY BEHAVIOR; KYNURENIC ACID; MALE; MOOD DISORDERS; NEURONS; OBESITY; RATS; RATS, WISTAR; SEROTONIN; TRYPTOPHAN; WEIGHT GAIN;

EID: 84874098768     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00373.2012     Document Type: Article

References (81)

1. Adeva MM, Calviño J, Souto G, Donapetry C. Insulin resistance and the metabolism of branched-chain amino acids in humans. Amino Acids 43: 171-181, 2012.
2. Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, Cope MB, Riley WT, Vreeland B, Hibbeln JR, Alpert JE. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med 36: 341-350, 2009.
3. An J, Muoio DM, Shiota M, Fujimoto Y, Cline GW, Shulman GI, Koves TR, Stevens R, Millington D, Newgard CB. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 10: 268-274, 2004.
4. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24: 1069-1078, 2001.
5. Beal MF, Matson WR, Swartz KJ, Gamache PH, Bird ED. Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. J Neurochem 55: 1327-1339, 1990.
6. Birch PJ, Grossman CJ, Hayes AG. Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors. Eur J Pharmacol 151: 313-315, 1988.
7. Blokland A, Lieben C, Deutz NE. Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat. J Psychopharmacol 16: 39-49, 2002.
8. Bongiovanni R, Young D, Newbould E, Jaskiw GE. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine. Brain Res 1115: 26-36, 2006.
9. Carlsson M, Carlsson A. In vivo evidence for a greater brain tryptophan hydroxylase capacity in female than in male rats. Naunyn Schmiedebergs Arch Pharmacol 338: 345-349, 1988.
10. Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, Palma MJ, Roberts LD, Dejam A, Souza AL, Deik AA, Magnusson M, Fox CS, O'Donnell CJ, Vasan RS, Melander O, Clish CB, Gerszten RE, Wang TJ. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 125: 2222-2231, 2012.
11. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 3: A42, 2006.
12. Cruz AP, Frei F, Graeff FG. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49: 171-176, 1994.
13. Dranovsky A, Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry 59: 1136-1143, 2006.
14. Dringenberg HC, Hargreaves EL, Baker GB, Cooley RK, Vanderwolf CH. p-chlorophenylalanine-induced serotonin depletion: reduction in exploratory locomotion but no obvious sensory-motor deficits. Behav Brain Res 68: 229-237, 1995.
15. Dymek MP, le Grange D, Neven K, Alverdy J. Quality of life and psychosocial adjustment in patients after Roux-en-Y gastric bypass: a brief report. Obes Surg 11: 32-39, 2001.
16. Estil S, Haaskjold E, Bjerknes R, Refsum SB. Early cell kinetic effects of some drugs on the rat corneal and conjunctival epithelia. Acta Ophthalmol Scand 73: 496-500, 1995.
17. Faith MS, Matz PE, Jorge MA. Obesity-depression associations in the population. J Psychosom Res 53: 935-942, 2002.
18. Fernstrom JD. Aromatic amino acids and monoamine synthesis in the central nervous system: influence of the diet. J Nutr Biochem 1: 508-517, 1990.
19. Fernstrom JD. Branched-chain amino acids and brain function. J Nutr 135: 1539S-1546S, 2005.
20. Fernstrom JD. Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev 63: 484-546, 1983.
21. Fletcher EJ, Millar JD, Zeman S, Lodge D. Non-competitive antagonism of N-methyl-D-aspartate by displacement of an endogenous glycinelike substance. Eur J Neurosci 1: 196-203, 1989.
22. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 25: 148-198, 2002.
23. Freis ED. Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med 251: 1006-1008, 1954.
24. Gal EM, Sherman AD. L-kynurenine: its synthesis and possible regulatory function in brain. Neurochem Res 5: 223-239, 1980.
25. Gariepy G, Nitka D, Schmitz N. The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Int J Obes (Lond) 34: 407-419, 2010.
26. Gómez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 9: 568-578, 2008.
27. Gougeon R, Morais JA, Chevalier S, Pereira S, Lamarche M, Marliss EB. Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care 31: 128-133, 2008.
28. Han Q, Cai T, Tagle DA, Li J. Structure, expression, and function of kynurenine aminotransferases in human and rodent brains. Cell Mol Life Sci 67: 353-368, 2010.
29. Huffman KM, Shah SH, Stevens RD, Bain JR, Muehlbauer M, Slentz CA, Tanner CJ, Kuchibhatla M, Houmard JA, Newgard CB, Kraus WE. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 32: 1678-1683, 2009.
30. Kanai M, Funakoshi H, Takahashi H, Hayakawa T, Mizuno S, Matsumoto K, Nakamura T. Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain 2: 8, 2009.
31. Kaufman S. Tyrosine hydroxylase. Adv Enzymol Relat Areas Mol Biol 70: 103-220, 1995.
32. Kempermann G, Kronenberg G. Depressed new neurons-adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol Psychiatry 54: 499-503, 2003.
33. Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health 29: 115-129, 2008.
34. Lapin IP. Antagonism of kynurenic acid to anxiogens in mice. Life Sci 63: PL231-PL236, 1998.
35. Lapin IP. Neurokynurenines (NEKY) as common neurochemical links of stress and anxiety. Adv Exp Med Biol 527: 121-125, 2003.
36. Laugeray A, Launay JM, Callebert J, Surget A, Belzung C, Barone PR. Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety-and depression-like behaviours in mice: focus on individual differences. Pharmacol Biochem Behav 98: 161-168, 2011.
37. Levitt M, Spector S, Sjoerdsma A, Udenfriend S. Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guineapig heart. J Pharmacol Exp Ther 148: 1-8, 1965.
38. Lovenberg W, Jequier E, Sjoerdsma A. Tryptophan hydroxylation: measurement in pineal gland, brainstem, and carcinoid tumor. Science 155: 217-219, 1967.
39. Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R. The new "5-HT" hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 35: 702-721, 2011.
40. Markus CR. Dietary amino acids and brain serotonin function; implications for stress-related affective changes. Neuromolecular Med 10: 247-258, 2008.
41. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 13: 321-324, 1990.
42. Mollica RF, Cardozo BL, Osofsky HJ, Raphael B, Ager A, Salama P. Mental health in complex emergencies. Lancet 364: 2058-2067, 2004.
43. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy WS Jr, Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311-326, 2009.
44. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295: 1549-1555, 2006.
45. Ogden CL, Carroll MD, McDowell MA, Flegal KM. Obesity among adults in the United States-no statistically significant chance since 2003-2004. NCHS Data Brief: 1-8, 2007.
46. Pardridge WM. Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids. Neurochem Res 23: 635-644, 1998.
47. Pardridge WM, Choi TB. Neutral amino acid transport at the human blood-brain barrier. Fed Proc 45: 2073-2078, 1986.
48. Pardridge WM, Oldendorf WH. Kinetic analysis of blood-brain barrier transport of amino acids. Biochim Biophys Acta 401: 128-136, 1975.
49. Pellow S, File SE. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24: 525-529, 1986.
50. Pohjasvaara T, Vataja R, Leppavuori A, Kaste M, Erkinjuntti T. Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol 8: 315-319, 2001.
51. Prickaerts J, Raaijmakers W, Blokland A. Effects of myocardial infarction and captopril therapy on anxiety-related behaviors in the rat. Physiol Behav 60: 43-50, 1996.
52. Rezvani AH, Eddins D, Slade S, Hampton DS, Christopher NC, Petro A, Horton K, Johnson M, Levin ED. Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration. Neuroscience 154: 885-897, 2008.
53. Rodgers RJ, Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 21: 801-810, 1997.
54. Rodgers RJ, Johnson NJ. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52: 297-303, 1995.
55. Rosmond R. Obesity and depression: same disease, different names? Med Hypotheses 62: 976-979, 2004.
56. Rossi F, Schwarcz R, Rizzi M. Curiosity to kill the KAT (kynurenine aminotransferase): structural insights into brain kynurenic acid synthesis. Curr Opin Struct Biol 18: 748-755, 2008.
57. Sampey BP, Vanhoose AM, Winfield HM, Freemerman AJ, Muehlbauer MJ, Fueger PT, Newgard CB, Makowski L. Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity 19: 1109-1117, 2011.
58. Sachs-Ericsson N, Burns AB, Gordon KH, Eckel LA, Wonderlich SA, Crosby RD, Blazer DG. Body mass index and depressive symptoms in older adults: the moderating roles of race, sex, and socioeconomic status. Am J Geriatr Psychiatry 15: 815-825, 2007.
59. Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122: 509-522, 1965.
60. Schulz R, Beach SR, Ives DG, Martire LM, Ariyo AA, Kop WJ. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 160: 1761-1768, 2000.
61. Schwarcz R, Pellicciari R. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303: 1-10, 2002.
62. Scott KM, McGee MA, Wells JE, Oakley Browne MA. Obesity and mental disorders in the adult general population. J Psychosom Res 64: 97-105, 2008.
63. Shah SH, Crosslin DR, Haynes CS, Nelson S, Turer CB, Stevens RD, Muehlbauer MJ, Wenner BR, Bain JR, Laferrere B, Gorroochurn P, Teixeira J, Brantley PJ, Stevens VJ, Hollis JF, Appel LJ, Lien LF, Batch B, Newgard CB, Svetkey LP. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia 55: 321-330, 2012.
64. She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab 293: E1552-E1563, 2007.
65. Slotkin TA, Ryde IT, Levin ED, Seidler FJ. Developmental neurotoxicity of low dose diazinon exposure of neonatal rats: effects on serotonin systems in adolescence and adulthood. Brain Res Bull 75: 640-647, 2008.
66. Smith QR, Momma S, Aoyagi M, Rapoport SI. Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 49: 1651-1658, 1987.
67. Tai ES, Tan ML, Stevens RD, Low YL, Muehlbauer MJ, Goh DL, Ilkayeva OR, Wenner BR, Bain JR, Lee JJ, Lim SC, Khoo CM, Shah SH, Newgard CB. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 53: 757-767, 2010.
68. Tanke MA, Alserda E, Doornbos B, van der Most PJ, Goeman K, Postema F, Korf J. Low tryptophan diet increases stress-sensitivity, but does not affect habituation in rats. Neurochem Int 52: 272-281, 2008.
69. Vaidya VA, Duman RS. Depresssion-emerging insights from neurobiology. Br Med Bull 57: 61-79, 2001.
70. Vamos E, Pardutz A, Klivenyi P, Toldi J, Vecsei L. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection. J Neurol Sci 283: 21-27, 2009.
71. Van der Does AJ. The effects of tryptophan depletion on mood and psychiatric symptoms. J Affect Disord 64: 107-119, 2001.
72. van der Stelt HM, Broersen LM, Olivier B, Westenberg HG. Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats. Psychopharmacology 172: 137-144, 2004.
73. Vecsei L, Beal MF. Influence of kynurenine treatment on open-field activity, elevated plus-maze, avoidance behaviors and seizures in rats. Pharmacol Biochem Behav 37: 71-76, 1990.
74. Wadden TA, Stunkard AJ, Liebschutz J. Three-year follow-up of the treatment of obesity by very low calorie diet, behavior therapy, and their combination. J Consult Clin Psychol 56: 925-928, 1988.
75. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O'Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE. Metabolite profiles and the risk of developing diabetes. Nat Med 17: 448-453, 2011.
76. Wu JY, Kao HJ, Li SC, Stevens R, Hillman S, Millington D, Chen YT. ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease. J Clin Invest 113: 434-440, 2004.
77. Wurtman RJ, Hefti F, Melamed E. Precursor control of neurotransmitter synthesis. Pharmacol Rev 32: 315-335, 1980.
78. Würtz P, Mäkinen VP, Soininen P, Kangas AJ, Tukiainen T, Kettunen J, Savolainen MJ, Tammelin T, Viikari JS, Rönnemaa T, Kähönen M, Lehtimäki T, Ripatti S, Raitakari OT, Järvelin MR, Ala-Korpela M. Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes 61: 1372-1380, 2012.
79. Young SN. The use of diet and dietary components in the study of factors controlling affect in humans: a review. J Psychiatry Neurosci 18: 235-244, 1993.
80. Young SN, Smith SE, Pihl RO, Ervin FR. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87: 173-177, 1985.
81. Zarate CA Jr, Quiroz JA, Singh JB, Denicoff KD, De Jesus G, Luckenbaugh DA, Charney DS, Manji HK. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry 57: 430-432, 2005.